CLASS II ONGOING Device recall · Reported 22 Mar 2023 · FDA Enforcement Report

In Vitro Diagnostic (IVD) Panel BioFire BCID2 Panel recalled

BioFire Diagnostics is recalling In Vitro Diagnostic (IVD) Panel BioFire BCID2 Panel, distributed nationwide in the US. The recall was initiated on 1 Feb 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesPart Number: RFIT-ASY-0147 UDI: 0815381020338 Pouch Lot Number: 1766022
Quantity recalled2 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1251-2023
FDA event ID
91647
Recalling firm
BioFire Diagnostics, Salt Lake City, UT
Classification
Class II
Status
Ongoing
Recall initiated
1 Feb 2023
FDA classified
15 Mar 2023
Reported
22 Mar 2023
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Temperature Abuse

Timeline

1 Feb 2023Recall initiated by company
15 Mar 2023Classified by FDA+42 days
22 Mar 2023Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Due to temperature excursions with products (products being stored outside of the required temperature specifications) that may cause a reduction in performance. The temperature excursion was as a result of shipping delays.

Foods that need refrigeration and were stored or shipped too warm can grow harmful bacteria without any change in look or smell.

Product as listed by the FDA

In Vitro Diagnostic (IVD) Panel BioFire BCID2 Panel - REF RFIT-ASY-0147

Where it was distributed

U.S. Nationwide distribution in the states of FL and GA.

Nationwide FloridaGeorgia

Questions about this recall

Is In Vitro Diagnostic (IVD) Panel BioFire BCID2 Panel recalled?

Yes. BioFire Diagnostics recalled In Vitro Diagnostic (IVD) Panel BioFire BCID2 Panel on 1 Feb 2023. The recall is Class II and its status is Ongoing. Recall number Z-1251-2023.

Why was it recalled?

Due to temperature excursions with products (products being stored outside of the required temperature specifications) that may cause a reduction in performance. The temperature excursion was as a result of shipping delays.

Which lots are affected?

Part Number: RFIT-ASY-0147 UDI: 0815381020338 Pouch Lot Number: 1766022

Where was it sold?

U.S. Nationwide distribution in the states of FL and GA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from BioFire Diagnostics

All 44

Other Test Kits & Diagnostics recalls

All 2,656